Literature DB >> 27332989

The association between aspects of psychological resilience and subtypes of depression: implications for focussed clinical treatment models.

Christopher F Sharpley1,2, Vicki Bitsika2, Emmanuel Jesulola1, Kerry Fitzpatrick1, Linda L Agnew1.   

Abstract

OBJECTIVE: The aim of this study was to explore the association between Psychological Resilience (PR) and depression at global, dichotomous and subcomponent levels.
METHODS: A sample of 330 participants (117 males and 213 females) was randomly recruited from an electorate in Australia and completed the Zung Self-rating Depression Scale (SDS) and Connors-Davidson Resilience Scale (CDRISC).
RESULTS: PR was significantly and inversely associated with total SDS score at a global level. Only one of the three CDRISC factors was significantly associated with total SDS score and also with three of four SDS depression subtypes.
CONCLUSIONS: Because of the different nature and treatment requirements for depression subtypes, PR may be applicable to a limited range of depressed patients, particularly those who do not exhibit Anhedonia.

Entities:  

Keywords:  Coping; depression; resilience; treatment

Mesh:

Year:  2016        PMID: 27332989     DOI: 10.1080/13651501.2016.1199810

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  2 in total

1.  Resilience Intervention for Parents of Children with Autism: Findings from a Randomized Controlled Trial of the AMOR Method.

Authors:  Jessica M Schwartzman; Maria Estefania Millan; Mirko Uljarevic; Grace W Gengoux
Journal:  J Autism Dev Disord       Date:  2021-03-28

2.  Distinct neural correlates of trait resilience within core neurocognitive networks in at-risk children and adolescents.

Authors:  Allesandra S Iadipaolo; Hilary A Marusak; Shelley M Paulisin; Kelsey Sala-Hamrick; Laura M Crespo; Farrah Elrahal; Craig Peters; Suzanne Brown; Christine A Rabinak
Journal:  Neuroimage Clin       Date:  2018-06-27       Impact factor: 4.881

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.